Innoviva, Inc. (INVA)
21.80
+0.23
(+1.07%)
USD |
NASDAQ |
Feb 06, 16:00
21.81
+0.01
(+0.05%)
After-Hours: 20:00
Innoviva SG&A Expense (TTM) : 112.52M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 74.62M |
| Oramed Pharmaceuticals, Inc. | 7.17M |
| Theravance Biopharma, Inc. | 75.94M |
| Axsome Therapeutics, Inc. | 514.57M |
| Keros Therapeutics, Inc. | 45.77M |